Synergy in activating class I PI3Ks
- PMID: 25573003
- DOI: 10.1016/j.tibs.2014.12.003
Synergy in activating class I PI3Ks
Abstract
The class I phosphoinositide 3-kinases (PI3Ks) are lipid kinases that transduce a host of cellular signals and regulate a broad range of essential functions including growth, proliferation, and migration. As such, PI3Ks have pivotal roles in diseases such as cancer, diabetes, primary immune disorders, and inflammation. These enzymes are activated downstream of numerous activating stimuli including receptor tyrosine kinases, G protein-coupled receptors (GPCRs), and the Ras superfamily of small G proteins. A major challenge is to decipher how each PI3K isoform is able to successfully synergize these inputs into their intended signaling function. This article highlights recent progress in characterizing the molecular mechanisms of PI3K isoform-specific activation pathways, as well as novel roles for PI3Ks in human diseases, specifically cancer and immune diseases.
Keywords: cancer; lipid kinases; lipid signaling; phosphoinositide 3 kinases; phosphoinositides; primary immunodeficiencies.
Crown Copyright © 2014. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Class I phosphoinositide 3-kinase (PI3K) regulatory subunits and their roles in signaling and disease.Adv Biol Regul. 2020 Jan;75:100657. doi: 10.1016/j.jbior.2019.100657. Epub 2019 Sep 28. Adv Biol Regul. 2020. PMID: 31611073 Review.
-
Novel roles for class II Phosphoinositide 3-Kinase C2β in signalling pathways involved in prostate cancer cell invasion.Sci Rep. 2016 Mar 17;6:23277. doi: 10.1038/srep23277. Sci Rep. 2016. PMID: 26983806 Free PMC article.
-
Drugging the Phosphoinositide 3-Kinase (PI3K) and Phosphatidylinositol 4-Kinase (PI4K) Family of Enzymes for Treatment of Cancer, Immune Disorders, and Viral/Parasitic Infections.Adv Exp Med Biol. 2020;1274:203-222. doi: 10.1007/978-3-030-50621-6_9. Adv Exp Med Biol. 2020. PMID: 32894512 Review.
-
Molecular mechanism of activation of class IA phosphoinositide 3-kinases (PI3Ks) by membrane-localized HRas.J Biol Chem. 2017 Jul 21;292(29):12256-12266. doi: 10.1074/jbc.M117.789263. Epub 2017 May 17. J Biol Chem. 2017. PMID: 28515318 Free PMC article.
-
Class I PI3K Biology.Curr Top Microbiol Immunol. 2022;436:3-49. doi: 10.1007/978-3-031-06566-8_1. Curr Top Microbiol Immunol. 2022. PMID: 36243838
Cited by
-
Polyphosphoinositide-Binding Domains: Insights from Peripheral Membrane and Lipid-Transfer Proteins.Adv Exp Med Biol. 2019;1111:77-137. doi: 10.1007/5584_2018_288. Adv Exp Med Biol. 2019. PMID: 30483964 Free PMC article. Review.
-
GqPCR-stimulated dephosphorylation of AKT is induced by an IGBP1-mediated PP2A switch.Cell Commun Signal. 2022 Jan 8;20(1):5. doi: 10.1186/s12964-021-00805-z. Cell Commun Signal. 2022. PMID: 34998390 Free PMC article.
-
Challenges for the Clinical Development of PI3K Inhibitors: Strategies to Improve Their Impact in Solid Tumors.Cancer Discov. 2019 Apr;9(4):482-491. doi: 10.1158/2159-8290.CD-18-1175. Epub 2019 Mar 13. Cancer Discov. 2019. PMID: 30867161 Free PMC article. Review.
-
Epstein-Barr Virus Susceptibility in Activated PI3Kδ Syndrome (APDS) Immunodeficiency.Front Immunol. 2018 Jan 16;8:2005. doi: 10.3389/fimmu.2017.02005. eCollection 2017. Front Immunol. 2018. PMID: 29387064 Free PMC article. Review.
-
Structure of the phosphoinositide 3-kinase (PI3K) p110γ-p101 complex reveals molecular mechanism of GPCR activation.Sci Adv. 2021 Aug 27;7(35):eabj4282. doi: 10.1126/sciadv.abj4282. Print 2021 Aug. Sci Adv. 2021. PMID: 34452907 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
